Haytham Elgammal

Internal Medicine clinician in Miami, Florida — also lists obesity medicine in the CMS registry.

Practice Details

Address
7031 SW 62nd
Miami, FL 33143
Taxonomy
Internal Medicine
NPPES Enumeration
Listed with NPPES since 2019
Sole Proprietor
No
Provider Gender (NPPES)
Male
NPPES Record Updated
October 2019

Specialty taxonomies on file (2)

  • Bariatric Surgery
    Surgery
  • Internal Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Haytham Elgammal is an Internal Medicine clinician in Miami whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 1604 Internal Medicine practices in Miami carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • •A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • •Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • •A discussion of GLP-1 options for diabetes and/or weight management.
  • •A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Haytham Elgammal's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 305-284-7700.

GLP-1 access in Miami, Florida

Adult obesity rate
30.1%
#33 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$189/mo
Typical Florida telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Florida Medicaid, obesity indication

About 30.1% of Florida adults have obesity (BMI 30+), ranking the state #33 of 50 (CDC BRFSS). Our directory currently lists 197 GLP-1-relevant clinics in Miami. If a cash-pay route makes more sense, compounded semaglutide through Florida telehealth averages about $189/mo — well below brand-name Wegovy or Zepbound.

Explore more Florida options on the best Florida GLP-1 providers page, browse every Miami listing in the Miami clinic directory, or read the Florida Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Miami

Other Miami listings in the same directory tier:

Halley Francis
Internal Medicine
Luis Samos
Internal Medicine
Eddie Gomez
General Practice

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Florida addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Florida telehealth partners:

Featured Partners · Miami

Featured GLP-1 providers serving Miami

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 194 GLP-1 providers serving Miami ↓

See more Miami options on the Miami clinic directory, our Miami GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Miami obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Haytham Elgammal's specialty taxonomy but not the specific medications it prescribes or its current service menu. Haytham Elgammal is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 305-284-7700 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Haytham Elgammal's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Haytham Elgammal is located at 7031 SW 62nd, Miami, FL 33143. The phone number listed in the registry is 305-284-7700. Its full record is public in the CMS National Provider registry under NPI 1841832359.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Haytham Elgammal is currently accepting new patients. Call the practice at 305-284-7700 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.